SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is rallying as investors react to a strategic $14.2 billion deal to regain full ownership of its Ireland-based Fab 34, a move perceived as a major vote of confidence in the company's manufacturing and AI-driven growth trajectory. The community is actively debating the stock's future, with many interpreting the heavy capital reinvestment as a clear indicator that major new customer contracts are imminent.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is currently trending following news that it has secured FDA approval for VYKAT XR, the first therapy developed to treat hyperphagia in Prader-Willi syndrome. The community is actively discussing the stock's significant price momentum, debating the potential for a future acquisition by a larger pharmaceutical player, and evaluating the long-term commercial execution of this newly approved asset.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as the market reacts to the company's latest subscription price hikes, which analysts view as a strategic move to fund a massive content budget and solidify profitability. While some retail investors are voicing frustration over recurring cost increases, the community is heavily focused on the stock's relative strength and technical breakout potential, with many discussing its role as a hedge against broader market volatility.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

The Next Bitcoin

Investors are rallying behind this Solana-based meme coin as a satirical movement intended to mock established market structures, with community members actively comparing its long-term potential to industry giants. Discussions are currently dominated by enthusiasts promoting the token's cultural narrative and its goal of creating viral engagement within the broader crypto ecosystem.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Neurocrine Biosciences is trending as the market reacts to the definitive agreement to acquire Soleno Therapeutics for $2.9 billion. Community sentiment is mixed, with active debate regarding whether the acquisition effectively addresses Neurocrine's need for pipeline growth or if the premium paid for the rare-disease asset signals a strategic overpay.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is seeing significant investor interest driven by a combination of resilient pricing power in its core smokeable business and ongoing momentum in its smoke-free portfolio, particularly with the growth of its on! nicotine pouches. The community is actively debating the company's long-term pivot from traditional cigarettes toward smoke-free alternatives, with many highlighting the stock's role as a classic, high-yield defensive play in a volatile market.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines is experiencing a significant surge in momentum as the company reports positive trial results for its essential tremor and epilepsy therapies, driving multiple analyst price target upgrades. While the community is debating the impact of a recent large-scale public offering, many investors remain bullish on the long-term potential of the company's CNS-focused pipeline.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as shareholders analyze the strategic implications of parent company Centurium Capitals acquisition of Blue Bottle Coffee. While the community remains divided over potential conflicts of interest versus synergistic growth, investors are closely monitoring for signs of a long-anticipated U.S. exchange relisting and are actively debating the stock's future valuation amid shifting institutional ownership.

A2Z Cust2Mate Solutions Corp. is a technology company, which engages in the development and commercialization of retail smart cart solutions for large grocery stores and supermarkets. It operates through the Smart Carts and Precision Metal Parts segments. The Smart Carts segment offers retail automation solutions. Its platform enables seamless in-cart scanning and payment, allowing shoppers to bypass checkout lines while receiving real-time customized offers and product recommendations. The Precision Metal Parts segment includes the manufacturing and sale of precision metal parts. The company was founded by Joseph Bentsur on January 15, 2018 and is headquartered in Vancouver, Canada.

A2Z Cust2Mate Solutions Corp.

A2Z Smart Technologies Corp.

A2Z Smart Technologies is trending following a major five-year strategic agreement to deploy 4,000 smart shopping carts at Carrefour Israel, a move the community views as a significant model for global scalability. Investors are actively discussing the company's retail media expansion, potential for recurring revenue, and bullish technical setups, with many highlighting institutional interest from significant fund stakes as a vote of confidence in the stock's long-term growth trajectory.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is currently trending due to intense speculation surrounding a potential short squeeze, driven by extremely limited share availability for borrowing and surging borrow fees. The community is actively debating the stock's volatility, with many retail traders drawing comparisons to historical meme stock runs while critics emphasize the company's lack of revenue and potential for dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>TD Cowen raised its price target on Rivian shares to $20 from $17.</li><li>The firm estimates that annual sales for R2 could eventually range from roughly 212,000 to 335,000 vehicles.</li><li>Rivian plans to price the R2 SUV at roughly $45,000 with roll-out beginning in the second-quarter.&nbsp;</li></ul>Rivian Automotive Inc. (RIVN) received a vote of confidence from TD Cowen, which upgraded the electric vehicle maker’s stock to a ‘Buy’ rating from ‘Hold’ while lifting its price target.&nbsp;TD Cowen raised its price target on Rivian shares to $20 from $17, according to TheFly.&nbsp;<h2 class="st-heading-2">R2 Growth Potential</h2>The revised outlook comes as the firm evaluated potential demand for Rivian’s upcoming R2 vehicle platform, which could significantly expand the company’s market reach.TD Cowen’s analysts estimate that demand for R2 could eventually range from roughly 212,000 to 335,000 vehicles. They noted that this projection may exceed current Wall Street expectations for 2027.&nbsp;Following the upgrade,&nbsp;<a href="https://stocktwits.com/symbol/RIVN">Rivian Automotive stock</a> traded over 4% higher in Tuesday’s premarket.&nbsp;On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘neutral’ territory the previous day amid ‘low’ message volume levels.&nbsp;<h2 class="st-heading-2">The Affordable R2 Lineup&nbsp;</h2>The next-generation EVs are expected to target a broader, more affordable segment of the EV market than Rivian’s current R1 lineup. By expanding into a larger customer base, Rivian aims to ramp up production and improve long-term revenue growth.Rivian plans to price the R2 SUV at roughly $45,000, cheaper than the R1 models that start around $70,000. The R2 roll-out will begin in the second-quarter (Q2).&nbsp;In its fourth-quarter (Q4) earnings call, Rivian CFO Claire McDonough noted that the operational complexity tied to the R2 rollout could put pressure on automotive gross profit in Q2 and the third quarter of 2026, even though total gross profit is expected to rise compared with the previous year.RIVN stock has gained over 57% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-ceo-jensen-huang-frames-ai-as-foundational-infrastructure-ahead-of-gtc-event-next-week/cZdotbFRI7J">Nvidia CEO Jensen Huang Frames AI As ‘Foundational Infrastructure’ Ahead Of GTC Event Next Week</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Rivian logo is on display during the 2025 Los Angeles Auto Show at the Los Angeles Convention Center on November 23, 2025 in Los Angeles, California

RIVN Stock Gains 4% Pre-Market After TD Cowen Upgrade: Analyst Sees Strong Demand For Upcoming R2 Models

Rivian Automotive Inc. (RIVN) received a vote of confidence from TD Cowen, which upgraded the electric vehicle maker’s stock to a ‘Buy’ rating from ‘Hold’ while lifting its price target. 

Equity

The firm believes the new lineup could significantly expand Rivian's addressable EV market.

<ul class="summary-bullets"><li>Analyst Stephen Gengaro highlighted significant progress in Tesla’s full self-driving (FSD) system.</li><li>Stifel highlighted gains in Tesla’s robotaxi ambitions, noting expansion in Austin and the Bay Area.</li><li>In the third quarter of 2025, Tesla reported delivering 497,099 vehicles.</li></ul>Stifel has raised its price target for Tesla, Inc. (TSLA) to $508 from $483, while maintaining a ‘Buy’ recommendation, citing strong third-quarter (Q3) results and promising advances in autonomous driving as justification for the boost.The new price target signals a 25% upside to the company’s closing price as of Friday.<a href="https://stocktwits.com/symbol/TSLA">Tesla’s stock</a> traded over 1% lower in Monday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘neutral’ territory amid ‘normal’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:934/107;" src="https://news.stocktwits-cdn.com/Screenshot_2025_11_17_083637_png_32222ae1d6.webp" alt="TSLA’s Sentiment Meter and Message Volume as of 08:00 a.m. ET on Nov. 17, 2025 | Source: Stocktwits" width="934" height="107"><figcaption>TSLA’s Sentiment Meter and Message Volume as of 08:00 a.m. ET on Nov. 17, 2025 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Why Stifel Is Bullish</h2>According to a CNBC&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/11/17/tesla-will-rally-more-than-25percent-as-it-makes-progress-in-robotaxi-development-stifel-says.html">report</a>, analyst Stephen Gengaro points to what he calls meaningful progress in Tesla’s full self-driving (FSD) system, noting that upcoming updates will introduce reasoning capabilities like improved decision-making for parking.&nbsp;He also highlighted gains in Tesla’s robotaxi ambitions, noting expansion in Austin and the Bay Area as well as planned entry into eight to ten U.S. metro areas by the end of 2025.“We also believe TSLA’s AI-based Full Self-Driving (FSD) initiative has the potential to generate significant value through both sales of FSD, possible licensing agreements, and as critical part of longer-term Cybercab (Robotaxi) initiatives,” said Genargo.<h2 class="st-heading-2">Sales Momentum</h2>Tesla’s recent financials also justify the optimism, according to the analyst. Despite near-term risks, such as expiration of the U.S. electric-vehicle tax credit, Gengaro remains confident in Tesla’s multi-year trajectory.In the third quarter of 2025, Tesla&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-reports-7-percent-rise-in-q3-deliveries/chCrXlDR3Ow">reported</a> delivering 497,099 vehicles, marking a 7.4% year-over-year growth and its highest quarterly deliveries to date.The company pulled in $28.10 billion in revenue in Q3, easily outpacing&nbsp;Koyfin’s forecast of $26.7 billion. Q3 revenue rose 12% year-on-year.&nbsp;TSLA stock has gained over 19% in the last 12 months.&nbsp;Also See:<a href="https://stocktwits.com/news-articles/markets/equity/why-did-dell-technologies-tumble-5-percent-pre-market-today/cLPkvbDREIw"> Why Did Dell Technologies Tumble 5% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tesla, Inc. (NASDAQ: TSLA) releases a financial earnings report on October 23, 2025. (Photo by Mike Campbell/NurPhoto via Getty Images)

Tesla’s Robotaxi Push Drives Stifel’s 25% Upside Call 

Analyst Stephen Gengaro highlighted significant progress in Tesla’s full self-driving (FSD) system.

Stifel cited strong third-quarter results and promising advances in autonomous driving as drivers for the price target boost.

Morgan Stanley on Thursday raised its price target on XPeng (XPEV) to $28 from $26 while keeping an ‘Overweight’ rating on the shares.The new price target implies a 37% upside to the stock’s closing price on Wednesday.Constant competition and year-to-date stock outperformance "may aggravate near-term volatility," Morgan Stanley noted. However, the firm stays constructive on XPeng's model pipeline and AI-related initiatives.Morgan Stanley views the G7, powered by the in-house developed AI Turing chip, which XPeng launched at a pre-sale price of RMB235,800 ($32,781), as "just the first step in pioneering a breakthrough," the analyst said.XPeng unveiled the G7, an all-electric mid-size SUV, on Wednesday. The company plans to start delivering the vehicle in the third quarter. It will compete against the Tesla Model Y, which starts at RMB263,500 in the Chinese market.The company also launched the Max variant of its all-electric hatchback sedan, MONA M03, in China late last month.The company is now looking to launch the new P7 electric sedan later this year in the third quarter.Last month, XPeng said that it expects to deliver between 102,000 and 108,000 vehicles in the second quarter, representing a 257.5% year-on-year (YoY) increase.On Stocktwits, retail sentiment around XPeng rose from ‘bearish’ to ‘neutral’ over the past 24 hours while message volume remained ‘low.’<figure class="image"><img style="aspect-ratio:628/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_12_at_1_27_48_PM_png_2f1691dbbc.webp" alt="XPEV's Sentiment Meter and Message Volume as of 1:30 p.m. ET on Jun 12, 2025 | Source: Stocktwits" width="628" height="64"><figcaption>XPEV's Sentiment Meter and Message Volume as of 1:30 p.m. ET on Jun 12, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user noted how Thursday’s developments would have taken short sellers by surprise.<stembedurl>https://stocktwits.com/mymy2009/message/617718575</stembedurl>According to data from Koyfin, 21 of 28 analysts covering XPeng rate it a ‘Buy’ or higher, while six rate it a ‘Hold’ and one rates it a ‘Strong Sell.’ The stock has an average price target of $25.32.<a href="https://stocktwits.com/symbol/XPEV">XPEV stock</a> is up by about 68% this year and has risen nearly 159% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/larry-ellison-overtakes-jeff-bezos-mark-zuckerberg-oracle-stock/chlgEkLRRG3">Larry Ellison Overtakes Bezos, Zuckerberg To Become World’s 2nd Richest Person As Oracle Stock Rips Post Earnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.(Exchange Rate: 1 RMB = 0.14 USD)

A storefront of XPeng Motors, a leading Chinese electric vehicle manufacturer, displays its latest models at a shopping mall in China | Photo by Cheng Xin/Getty Images

XPeng Gets A Price Target Hike From Morgan Stanley, Retail Wonders What Happened To Short Sellers

The new price of $28 target implies a 37% upside to the stock’s closing price on Wednesday. 

Chinese EV maker XPeng Motors (XPEV) <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/05/28/3089739/0/en/XPENG-Redefines-Mainstream-EV-Market-with-MONA-M03-Max-World-s-Only-AI-Powered-Smart-Driving-at-US-20-000.html">launched</a> the Max variant of its all-electric hatchback sedan MONA M03 in China on Wednesday, sending NYSE-listed shares of the company trading 1% higher midday.The Mona M03 is priced under the $20,000 or RMB 150,000 segment in China. XPeng debuted the MONA M03 in August and started deliveries in September. The company has delivered 120,000 units of the vehicle as of May 2025.With the launch of the MONA M03 Max variant, the company has introduced a city-level advanced drive assistance system (ADAS) to the $20,000 price point, XPeng said, adding that the ADAS system, called AI Turing Smart Driving, is the only advanced ADAS available in this price segment globally.No added cost or subscriptions are required to access the company’s smart driving system, which can accurately detect over 50 road elements from traffic signs to complex obstacles, the company said.The vehicle also features a smart cockpit with features outperforming higher-priced vehicles, as well as the previously launched MONA M03 variant, the company said. The Max variant offers two range options of 600 km and 502 km.Earlier this month, XPeng reported first-quarter earnings that surpassed Wall Street expectations owing to strong vehicle deliveries of 94,008 units. The firm said it expects to deliver between 102,000 and 108,000 vehicles, representing a YoY increase of 257.5%, in the second quarter.The company sees second-quarter (Q2) revenue between RMB17.5 billion and RMB18.7 billion, representing a YoY increase of approximately 115.7% to 130.5%.XPeng is also looking to debut an all-new model called the XPeng G7 SUV in June in the RMB 250,000 SUV segment to increase delivery momentum.On Stocktwits, retail sentiment around XPEV fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours while message volume dropped from ‘extremely high’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:628/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_28_at_1_21_38_PM_png_20906e7ee7.webp" alt="XPEV's Sentiment Meter and Message Volume as of 1:20 p.m. ET on May 28, 2025 | Source: Stocktwits" width="628" height="63"><figcaption>XPEV's Sentiment Meter and Message Volume as of 1:20 p.m. ET on May 28, 2025 | Source: Stocktwits</figcaption></figure> According to data from Koyfin, 20 of the 28 analysts covering XPeng rate it ‘Buy’ or higher, seven rate it ‘Hold’, while one rates it a ‘Strong Sell’.The stock has an average price target of $25.03, representing an upside of over 25% from current trading levels.<a href="https://stocktwits.com/symbol/XPEV/sentiment">XPEV stock</a> is up by about 68% this year and 130% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/boston-scientific-discontinues-worldwide-sales-of-acurate-aortic-valve-systems/ch0oF7wRbsN">Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

XPeng Launches MONA M03 Max With ADAS In $20,000 Price Segment, But Retail’s Not Super Excited

The vehicle also features a smart cockpit with features that outperform those of higher-priced vehicles, as well as the previously launched MONA M03 variant, the company said.

Multiple brokerages, including Bank of America, raised their price target on shares of Chinese EV maker XPeng Inc. (XPEV) after the company’s first-quarter earnings exceeded Wall Street expectations.Macquarie analyst Eugene Hsiao upgraded XPeng to ‘Outperform’ from ‘Neutral’ with a price target of $24, up from $22.XPeng reported adjusted and diluted loss per American depository share (ADS) of RMB0.45 ($0.062) for the first quarter, compared with a loss of RMB1.49 for the first quarter of 2024, and below an estimated loss of RMB1.51 per share.Hsiao noted that XPeng continues to execute ahead of expectations in a difficult domestic EV market and that strong launches of the M03 MAX and G7 could drive momentum in the upcoming quarters.XPeng said on Wednesday that it expects to deliver between 102,000 and 108,000 vehicles in the second quarter, representing a 257.5% year-on-year (YoY) increase.The company also sees Q2 revenue between RMB17.5 billion and RMB18.7 billion, representing a YoY increase of approximately 115.7% to 130.5%, above an analyst estimate of RMB17.22 billion.Bank of America raised its price target on XPeng to $29 from $27 while keeping a ‘Buy’ rating on the shares and expressed optimism for the company’s upcoming vehicle launches.Bernstein analyst Eunice Lee, meanwhile, raised the firm’s price target to $19 from $18 while keeping a ‘Market Perform’ rating on the shares.Notably, XPeng has not turned a profit since its founding in 2014.On Stocktwits, retail sentiment around XPEV fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours while message volume jumped from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:623/66;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_22_at_9_50_04_AM_png_9522d31bfc.webp" alt="XPEV's Sentiment Meter and Message Volume as of 9:50 a.m. ET on May 22, 2025 | Source: Stocktwits" width="623" height="66"><figcaption>XPEV's Sentiment Meter and Message Volume as of 9:50 a.m. ET on May 22, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/XPEV">XPEV stock</a> is up by about 80% this year and by about 138% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/vigil-neuroscience-stock-triples-on-acquisition-by-sanofi/ch09fn3RbpN">Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.(Exchange Rate: 1 RMB = 0.14 USD)

XPeng Stock Gets Price Target Hikes From Macquarie, Bernstein, BofA After Upbeat Q1: Retail’s Cautiously Optimistic

As per Macquarie analyst Eugene Hsiao, XPeng continues to execute ahead of expectations in a difficult domestic EV market.

Shares of Chinese EV maker XPeng Inc. (XPEV) are trading nearly 7% higher in pre-market on Wednesday after its first-quarter earnings report beat Wall Street expectations. &nbsp;The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.xiaopeng.com/news-releases/news-release-details/xpeng-reports-first-quarter-2025-unaudited-financial-results">reported</a> Q1 revenue of RMB15.81 billion ($2.19 billion), a 141.5% increase year-over-year (YoY), and above an analyst estimate of RMB15.69 billion, as per Finchat data.Adjusted and diluted loss per American depository share (ADS) was RMB0.45, compared with RMB1.49 for the first quarter of 2024, and below an estimated loss of RMB1.51 per share.The increase in revenue was spurred by the increase in vehicles delivered by the company in the three months through the end of March. XPeng delivered 94,008 vehicles in the period, marking a year-on-year growth of 331%.XPeng CEO Xiaopeng He said that quarterly deliveries hit a historical high despite seasonality for car sales.“We remain committed to our steadfast long-term growth strategy and continue to launch more blockbuster products,” He said. “We are just beginning to unleash our growth potential.”Gross margin stood at 15.6% for the first quarter, as compared to 12.9% from a year earlier.The company ended the quarter with cash and cash equivalents, restricted cash, short-term investments, and time deposits of RMB45.28 billion, compared with RMB41.96 billion as of December 31, 2024.For the second quarter, XPeng expects to deliver between 102,000 and 108,000 vehicles, representing a YoY increase of 257.5%.The company sees Q2 revenue between RMB17.5 billion and RMB18.7 billion, representing a YoY increase of approximately 115.7% to 130.5%, and above an analyst estimate of RMB16.89 billion.On Stocktwits, retail sentiment around XPeng rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours while message volume rose from ‘normal’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:628/65;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_21_at_8_25_08_AM_png_28fc32d571.webp" alt="XPEV's Sentiment Meter and Message Volume as of 8:25 a.m. ET on May 21, 2025 | Source: Stocktwits" width="628" height="65"><figcaption>XPEV's Sentiment Meter and Message Volume as of 8:25 a.m. ET on May 21, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed optimism for the company reaching profitability in the next 12 months after the Q1 earnings report.<stembedurl>https://stocktwits.com/bjbartelt/message/615340658</stembedurl>XPeng has not turned a profit since its founding in 2014.<a href="https://stocktwits.com/symbol/XPEV">XPEV stock</a>, however, is up by over 70% this year and has more than doubled its value over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/medtronic-announes-split-of-diabetes-business/ch0ec0dRbYg">Medtronic Announces Split Of Diabetes Business As Standalone Public Company: Retail’s Unmoved</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.(Exchange Rate: 1 RMB = 0.14 USD)

XPeng Stock Rises Pre-Market On Upbeat Q1 Earnings, Strong Q2 Forecast: Retail Turns Bullish

For the second quarter, XPeng expects to deliver between 102,000 and 108,000 vehicles, representing a YoY increase of as much as 257.5%.

NYSE-listed shares of Chinese EV maker XPeng Inc (XPEV) fell nearly 7% by Tuesday noon despite the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.xiaopeng.com/news-releases/news-release-details/xpeng-reports-fourth-quarter-and-fiscal-year-2024-unaudited">reporting</a> better than expected earnings in the fourth quarter and issuing a strong guidance for the first quarter of 2025.For the fourth quarter (Q4) of 2024, the company reported total revenue of RMB 16.11 billion ($2.21 billion), marking a growth of 23.4% year-on-year (YoY), compared to an analyst estimate of RMB16.15 billion, according to FinChat data. Loss per ordinary share came in at RMB 0.73 ($0.10), lower than an estimated loss of $0.20.The company expects its first quarter 2025 total revenue to be in the range of RMB 15 billion and RMB 15.7 billion, marking a YoY jump of up to 140%, on the back of strong delivery numbers.The company expects to deliver between 91,000 and 93,000 electric vehicles (EVs) in the three months through the end of March, significantly higher than the 21,821 vehicles it delivered in the corresponding quarter last year.XPeng CEO Xiaopeng He said the company is “well positioned” to significantly expand its market share in the EV industry in both China and abroad.The firm officially entered the U.K. market earlier this year, marking its latest expansion effort in Europe. By the end of 2025, the company aims to establish a presence in <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.xpeng.com/news/0194f9d174999467d6e98a0282160052">60 countries and regions</a>.Meanwhile, Xpeng launched the updated versions of its G6 and G9 SUVs earlier this month in China.On Stocktwits, retail sentiment shifted from “bullish” to “extremely bullish” (79/100), coupled with extremely high message volume.&nbsp; &nbsp;<figure class="image"><img style="aspect-ratio:1304/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_18_at_11_12_37_AM_png_e4f0b840c8.webp" alt="XPeng’s Sentiment Meter and Message Volume as of 11:14 a.m. ET on March 18, 2025 | Source: Stocktwits" width="1304" height="314"><figcaption>XPeng’s Sentiment Meter and Message Volume as of 11:14 a.m. ET on March 18, 2025 | Source: Stocktwits</figcaption></figure>NYSE-listed <a href="https://stocktwits.com/symbol/XPEV">shares of XPeng</a> have risen over 100% in 2025 and by over 130% in the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/bakkt-stock-tumbles-premarket-on-q4-earnings-delay-non-renewal-of-commercial-agreements/ch7KILaRbcV">Bakkt Stock Tumbles Premarket On Q4 Earnings Delay, Non-Renewal Of Commercial Agreements — Retail’s Still Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.Exchange Rate: 1 RMB = $0.14

A newly released G6 new energy model is displayed at the flagship store of Xiaopeng Motors in Shanghai, China on March 14, 2025. (Photo credit should read CFOTO/Future Publishing via Getty Images)

XPeng Forecasts Q1 Revenue To More Than Double But Stock Slides After Massive Gains In 2025: Retail Goes Extreme Bullish

XPeng expects its total revenue for the first quarter of 2025 to be between RMB 15 billion and RMB 15.7 billion, marking a year-on-year jump of up to 140% on the back of strong delivery numbers.

VanEck ETF Trust - VanEck Low Carbon Energy ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

SMOG
VanEck Low Carbon Energy ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest SMOG News

SMOGVanEck Low Carbon Energy ETF